RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

Go back to RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
(NASDAQ: RXST) Delayed: 5.39 --0 (-0%)
Previous Close $5.39    52 Week High
Open $5.39    52 Week Low
Day High $5.39    P/E N/A 
Day Low $5.39    EPS
Volume 300